Your session is about to expire
← Back to Search
Magnetic Mitohormesis Therapy for Frailty in Older Adults
Study Summary
This trial will test whether twice-weekly MMT can improve physical function in adults with limited physical ability.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have no health conditions that prevent me from undergoing tests or treatments.I have not had major surgery in the last 6 months.I haven't changed my prescription medications significantly in the last 3 months.I have some difficulty with physical activities.I have a history of cancer.I have a history of a disease that affects the brain or nerves.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Delayed intervention
- Group 2: Immediate intervention
Frequently Asked Questions
Are there any opportunities remaining to participate in this trial?
"As per clinicaltrials.gov, this medical research endeavour is actively recruiting participants. The trial was initially registered on April 26th 2023 and the most recent update occurred on July 3rd of the same year."
What is the current enrollment cap for this research-based project?
"Affirmative. Clinicaltrials.gov states that this clinical trial is currently enrolling patients, with 30 participants needed from a single site. The study was first announced on April 26th 2023 and last edited on July 3rd of the same year."
What is the ultimate aim of this investigation?
"This clinical trial's primary outcome will be quantified using a Likert scale over the course of 24 weeks. Secondary measurements include daily step count, grip strength, and research-based quality of life scores (RAND Short Form-12). The higher each score is, the better it indicates for patient outcomes."
Share this study with friends
Copy Link
Messenger